Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Taraboletti

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|August 15, 1985
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissuesB Bottazzi, P Ghezzi, G Taraboletti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5F A van den Brûle, V Castronovo, S Ménard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
The microtubule-affecting drug paclitaxel has antiangiogenic activityD Belotti, V Vergani, T Drudis, et al.
International Journal of Cancer|January 6, 1997
Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cellsG Taraboletti, P Borsotti, R G Chirivi, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agentL S Capolongo, G Balconi, P Ubezio, et al.
Blood|September 9, 1999
Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cellsR G Chirivi, G Taraboletti, M R Bani, et al.
International Journal of Cancer|September 9, 1992
Matrigel promotes retinoblastoma cell growth in vitro and in vivoA Albini, A Melchiori, A Garofalo, et al.
Thrombosis Research|May 11, 2016
PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1D Pinessi, C Foglieni, A Bugatti, et al.
British Journal of Cancer|September 13, 2007
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxelM Martinelli, K Bonezzi, E Riccardi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|August 15, 1985
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissuesB Bottazzi, P Ghezzi, G Taraboletti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5F A van den Brûle, V Castronovo, S Ménard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
The microtubule-affecting drug paclitaxel has antiangiogenic activityD Belotti, V Vergani, T Drudis, et al.
International Journal of Cancer|January 6, 1997
Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cellsG Taraboletti, P Borsotti, R G Chirivi, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agentL S Capolongo, G Balconi, P Ubezio, et al.
Blood|September 9, 1999
Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cellsR G Chirivi, G Taraboletti, M R Bani, et al.
International Journal of Cancer|September 9, 1992
Matrigel promotes retinoblastoma cell growth in vitro and in vivoA Albini, A Melchiori, A Garofalo, et al.
Thrombosis Research|May 11, 2016
PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1D Pinessi, C Foglieni, A Bugatti, et al.
British Journal of Cancer|September 13, 2007
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxelM Martinelli, K Bonezzi, E Riccardi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Pageof 6